The Top Analysis for Bristol-Myers Squibb Co. (BMY)

The top analysis was written by Sure Dividend Blog titled Blue Chip Stocks In Focus: Bristol-Myers Squibb

Is Bristol-Myers Squibb Co. (BMY) a buy?

Based on 2 suggestions, Bristol-Myers Squibb Co.(BMY) is recommended as a BUY at $62.62.

Are These Ratings Good?

Based on 2 ratings, the average Return is -24.67%.
The community has not been successfully rating this stock.

Forecast for Bristol-Myers Squibb Co. (BMY)

Based on the most recent price of $50.23,
the two year forecast for BMY is $57.51.
The four year forecast is $64.80
Forecast is based on the aggregate sentiment of users on the platform. The sentiment of top investors get a higher ranking when assessing the forecast.